You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 167 No. 4, February 26, 2007 TABLE OF CONTENTS
  Archives
  •  Online Features
  Correction
 This Article
 •PDF of this Correction
 •Original article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal

Error in Financial Disclosure in: The Latest and Greatest New Biomarkers: Which Ones Should We Measure for Risk Prediction in Our Practice?

Arch Intern Med. 2007;167(4):353.

Error in Financial Disclosure. In the Editorial by de Lemos titled "The Latest and Greatest New Biomarkers: Which Ones Should We Measure for Risk Prediction in Our Practice?" published in the December 11/25 issue of the ARCHIVES (2006;166:2428-2430), an error occurred in the Financial Disclosure on page 2429. The disclosure should have read as follows: Dr de Lemos has received grant support from Biosite (current) and Roche (>24 months previously); has received speaker honoraria from Biosite for educational programs; and is a consultant to Bayer Diagnostics, Biosite, and Inverness.







HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2007 American Medical Association. All Rights Reserved.